Anthem Biosciences IPO day 3: Issue subscribed over 60 times; check GMP, subscription status and other details

Anthem Biosciences’ IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional buyers drove this. The allotment date is 17 July, and shares are expected to list on 21 July at a premium of 28.07 per cent.